This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medical Device Industry Needs Miracle Cure

BOSTON ( MainStreet) -- Talk of health care costs usually revolves around prescription drugs, doctor visits, hospital stays and medical tests.

A growing debate, however, focuses on medical devices -- the physical equipment added to the body to alleviate symptoms, from contact lenses to prosthetic limbs, pacemakers to insulin pumps.

While the cost of life-saving medical devices can be astronomical in the U.S., a tax on them could drive away investment in them and punish small inventors. Is there a cure for this syndrome?

Among the industry leaders in this space are Johnson & Johnson (JNJ - Get Report), Abbot Laboratories (ABT - Get Report), Allergan (AGN), Covidien (COV), Becton, Dickinson and Co. (BDX - Get Report), St. Jude Medical (STJ - Get Report), Quest Diagnostics (DGX - Get Report), Boston Scientific (BSX - Get Report) and Smith & Nephew (SNN - Get Report).

The companies that make medical devices blame health care reform and shrinking venture capital pools for higher costs and a potential decrease in innovation.

A tax on medical devices is included in last year's health care reform package known as the Affordable Care Act, a 2.3% excise tax that will be levied on the total revenues of a company (regardless of whether it generates a profit) starting in 2013. It is anticipated that the tax will generate $20 billion in revenue over the course of a decade.

That tax has not surprisingly drawn fire from the medical device industry, and there has been another full-court press in recent days to remove it.

The Medical Device Manufacturers Association claims "many companies will owe more in taxes than they generate from their operations," and the result will be "devastating to innovation, patient care and job creation."

"The overwhelming majority of innovation from the medical device industry comes from smaller manufacturers who work closely with clinicians and engineers to develop the therapies and treatments of tomorrow," the group says in a policy statement. "If it is not repealed, this tax will stifle innovation, harm patient care and weaken the position of the United States as the global leader in medical device innovation."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ABT $49.27 0.53%
AGN $240.22 1.21%
BDX $141.50 -0.04%
BSX $18.26 1.50%
COV $106.71 -1.26%

Markets

DOW 18,126.12 -36.87 -0.20%
S&P 500 2,120.79 -2.69 -0.13%
NASDAQ 5,097.9760 -8.6170 -0.17%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs